REXULTI is just not approved for that treatment of men and women with dementia-connected psychosis without agitation that may well take place with dementia as a consequence of Alzheimer’s disorder. Ketamine also has clinically important interactions with other receptors, but these are typically mostly weaker than its NMDA receptor antagonism.31,34 https://greatn147uwx2.westexwiki.com/user